THBS1 and breast carcinoma: Treating mouse breast cancer cells with testosterone decreased de novo TSP1 synthesis (thus decreasing TSP1 expression at the mRNA and protein levels), and this effect was abrogated by administration of the anti-androgen flutamide [33], suggesting androgen-regulated angiogenesis.